Log in to search using one of your social media accounts:

 

Breast cancer: Recurrent fusions in endocrine-resistant disease.

Breast cancer: Recurrent fusions in endocrine-resistant disease. Nat Rev Clin Oncol. 2018 Feb 06;: Authors: Romero D PMID: 29405202 [PubMed - as supplied by publisher]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Nat Rev Clin Oncol Source Type: research

Related Links:

M árcio Debiasi, Carisi A. Polanczyk, Patrícia Ziegelmann, Carlos Barrios, Hongyuan Cao, James J. Dignam, Paul Goss, Brittany Bychkovsky, Dianne M. Finkelstein, Rodrigo S. Guindalini, Paulo Filho, Caroline Albuquerque, Tomás Reinert, Evandro de Azambuja, Olufunmilayo Olopade
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Contributors : Luciano Castiello ; Eleonora Aric ò ; Paola Sestili ; Filippo Belardelli ; Enrico Proietti ; Giovanna Schiavoni ; Domenica Monque ; Antonella Sistigu ; Rosanna Dattilo ; Fiorella Ciaffoni ; Mauro Biffoni ; Maria Ferrantini ; Manuela Iezzi ; Federica Moschella ; Alessi Lamolinara ; Ann Zeuner ; Anna M Pacca ; Daniele MacchiaSeries Type : Expression profiling by arrayOrganism : Mus musculusType I Interferons (IFN-I) are anti-viral and immuno-modulating cytokines involved in many steps across tumor initiation and progression. IFN-I act directly on tumor cells inhibiting cell growth and indirectly by acti...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Mus musculus Source Type: research
ConclusionsOur data support results from recent phase I clinical trials using combinations of AZD2014 and PTX for the treatment of solid tumors. Such combinations may also be employed for the design of novel targeted ATC treatment strategies.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
As a retired physician who has written a book about end-of-life issues for elderly patients, I have placed myself in an awkward position. According to most guidelines, at age 67, I am elderly. How will I approach the end of my life? Not only do my personal medical concerns career around in the echo chamber of my own mind, but I have the added challenge of trying to follow my own advice regarding end-of-life decision making. And, there are multiple examples of physicians who did not do that. Witness the example of Francis Warren, Harvard’s most famous surgeon of the 20th century, renowned for heroic cancer surgeries a...
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Physician Palliative Care Source Type: blogs
(Natural News) If you find out you have breast cancer, your first instinct might be to get rid of it using whatever means possible. Having a mastectomy isn’t a decision any woman takes lightly, of course, but, for many, the idea of sacrificing your breast to be cancer-free seems like a fair trade to make....
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Grandview Medical Center has named Jennifer De Los Santos as the medical director of the new Grandview Cancer Center.   Dr. De Los Santos has been nationally recognized for her work in radiation oncology, specifically her research in breast cancer treatment. Prior to joining Grandview, she was an associate scientist and professor at the University of Alabama at Birmingham in the department of radiation oncolog y. She also served as medical director of The Kirklin Clinic.  Dr. De Los Santos has…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Conditions:   HER2-positive Breast Cancer;   Breast Cancer;   Breast Cancer Stage;   Recurrent Breast Cancer;   Metastatic Breast Cancer;   HER2 Positive Breast Carcinoma Interventions:   Drug: Palbociclib;   Drug: T-DM1 Sponsors:   University of Arizona;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Guideposts to powerful treatments may be buried in the nation ’ s medical records. But there is no easy way to gather those records or to get them into a usable format.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Genetics and Heredity Tumors Cancer Breast Cancer Flatiron Health Inc National Cancer Institute Source Type: news
Recent survival results lead some to question the optimal sequence for trastuzumab emtansine in metastatic breast cancer.Chinese Clinical Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
(Mayo Clinic) In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology